Global Bone Cancer Drugs Market 2019-2023 - Increase in Strategic Alliances with Pharma Companies

News provided by

May 29, 2019, 16:15 ET

DUBLIN, May 29, 2019 /PRNewswire/ -- The "Global Bone Cancer Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.

Small and medium sized pharmaceutical and biotechnology vendors in the bone cancer market face a lack of funding to complete clinical trials and launch drugs for the treatment of various bone cancer indications. Pharmaceutical players face challenges with the distribution of drugs in the regions where the vendor does not operate. To overcome such challenges, these pharmaceutical companies are entering into strategic alliances with local pharmaceutical vendors for the manufacturing and distribution of drugs. The analysts have predicted that the bone cancer drugs market will register a CAGR of nearly 12% by 2023.

Growing risk factors

Growing risk factors associated with bone cancer will drive market growth in the forecast period. The growing prevalence of specific cancers, where radiation therapy has been a dominant treatment, is further stimulating market growth. Factors such as old age and family history of bone cancer are common risk factors for the disease.

Preference of surgery

The most preferred treatment options available to patients with bone cancer, is surgeries, due to their remissive nature. Surgery for bone cancer involves wide excision of the tumor, which includes removal of the tumor along with a part of healthy tissue around the tumor in all directions. The higher probability of recurrence of cancer tumors in the future reduces patient adherence to drug treatment landscape which poses a challenge to the market growth.

Competitive Landscape

The market appears to be concentrated and with the presence of a few companies. Factors such as the growing risk factors and increasing strategic alliances, will provide considerable growth opportunities to bone cancer drugs manufactures.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem
Market characteristics
Market segmentation analysis

PART 04: MARKET SIZING

Market definition
Market sizing 2018
Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

PART 06: PIPELINE

PART 07: MARKET SEGMENTATION BY INDICATION

Market segmentation by indication
Comparison by indication
Osteosarcoma - Market size and forecast 2018-2023
Ewing's sarcoma - Market size and forecast 2018-2023
Chondrosarcoma - Market size and forecast 2018-2023
Others - Market size and forecast 2018-2023
Market opportunity by indication

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

Market drivers
Market challenges

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

Overview
Landscape disruption
Competitive scenario

PART 14: VENDOR ANALYSIS

PART 15: APPENDIX

Vendors covered
Vendor classification
Market positioning of vendors
Amgen
Bayer AG
Bristol-Myers Squibb Company
Merck & Co. Inc.
Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/r/11davm

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets